See also this year's filing and all EDGAR filings for this company.
PDF Report 0001124105_2021_GYRE_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001124105, GYRE Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 89,510,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 433,000 |
| 3 | remainder_Assets | 4,903,000 |
| 4 | LiabilitiesCurrent | 17,796,000 |
| 5 | LiabilitiesNoncurrent | 981,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,606,913 |
| 9 | ResearchAndDevelopmentExpense | 51,148,418 |
| 10 | remainder_Expenses | 5,003,823 |
| 11 | remainder_Revenues | 18,876,419 |
| 12 | remainder_NetIncome | 1,439,517 |
| 13 | remainder_ComprehensiveNetIncome | -6,641 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 94,846,000 |
| 1 | Liabilities | 18,777,000 |
| 2 | Expenses | 72,759,154 |
| 3 | Revenues | 18,876,419 |
| 4 | StockholdersEquity | 76,069,000 |
| 5 | NetIncome | -52,443,218 |
| 6 | ComprehensiveNetIncome | -52,446,538 |
| 7 | BaseVar | 103,352,366 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.00 |
| 9 | EconomicCapitalRatio | 3.02 |
Edgar->Model Mapping
Feature Distribution
Change over Time
